Skip to main content
. 2015 Oct 16;7(3):2433–2454. doi: 10.18632/oncotarget.5693

Figure 2. Telomerase involvement.

Figure 2

Figure 2

A. Telomerase activity as measured by the TRAP assay before and after BRCA1 silencing. B. hTERT expression measured by real time PCR before and after BRCA1 silencing. “WT”- the wild type cells; “NC”- cells transfected with the negative control shRNA plasmid; “4” is clone # 4 in which BRCA1 silencing was optimal 6 months post shRNA transfection. C. Induction of telomerase activity by PHA in BRCA1/2 mutations carriers. Mononuclear cells were isolated from the BRCA1/2 mutation carriers as well as from the control group and subjected to PHA. Subsequently, telomerase activity was measured by the TRAP assay.